Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4447082 | 0.84 | — | — | |
| SCHEMBL37528 | 0.79 | — | — | |
| SCHEMBL25238705 | 0.79 | HDAC3 (0.44) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL11506222 | 0.79 | HDAC3 (0.44) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hydrochloric Acid SCHEMBL9687182 | 0.76 | — | — | |
| SCHEMBL21462107 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL3244716 | 0.76 | — | — | |
| SCHEMBL4293235 | 0.76 | — | — | |
| SCHEMBL307239 | 0.73 | FFAR3 (0.40) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL29071751 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985424-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES INC. (US) | 2011-07-26 | — | — | US | claimed |
| US-7981444-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2011-07-19 | — | — | US | claimed |
| EP-2325236-A1 | Dendritic polymers with enhanced amplification and interior functionality | Dendritic Nanotechnologies Inc. (US) | 2011-05-25 | — | — | EP | claimed |
| JP-2008545621-A | — | — | 2008-12-18 | — | — | JP | claimed |
| EP-1877103-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | claimed |
| WO-2006115547-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-11-02 | — | — | WO | claimed |
| US-10968176-B2 | Pyrrolidone derivatives, oligomers and polymers | NANOSYNTHONS LLC (US) | 2021-04-06 | — | — | US | disclosed |
| US-20190352258-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | NANOSYNTHONS LLC (US) | 2019-11-21 | — | — | US | disclosed |
| US-10420849-B2 | Pyrrolidone derivatives, oligomers and polymers | NANOSYNTHONS LLC (US) | 2019-09-24 | — | — | US | disclosed |
| US-20170246323-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | NANOSYNTHONS LLC (US) | 2017-08-31 | — | — | US | disclosed |
| EP-3194365-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | Nanosynthons LLC (US) | 2017-07-26 | — | — | EP | disclosed |
| WO-2016040962-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | NANOSYNTHONS LLC (US) | 2016-03-17 | — | — | WO | disclosed |
| EP-1877103-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | disclosed |
| US-20070244296-A1 | Dendritic Polymers with Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-10-18 | — | — | US | disclosed |
| EP-1737899-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2007-01-03 | — | — | EP | disclosed |
| WO-2006065266-A9 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006115547-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| WO-2006065266-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | MYD88, TLR3, TMEM97 | FFAR3 1358/4885HDAC3 3528/4885HDAC1 4450/4885 |
| US-10968176-B2 | Pyrrolidone derivatives, oligomers and polymers | POF1B, VGF, RAB5IF | FFAR3 977/4885HDAC3 3569/4885HDAC1 4294/4885 |
| US-20190352258-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | POF1B, VGF, RAB5IF | FFAR3 977/4885HDAC3 3569/4885HDAC1 4294/4885 |
| US-20170246323-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | POF1B, VGF, RAB5IF | FFAR3 827/4885HDAC3 3455/4885HDAC1 4328/4885 |
| US-10420849-B2 | Pyrrolidone derivatives, oligomers and polymers | POF1B, VGF, RAB5IF | FFAR3 827/4885HDAC3 3455/4885HDAC1 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.